loginLogin phone+44 203 371 1100

Medicines Company/The

Credit Sector:- Health Care

Country:- United States

Bond Document:- https://www.bondpdf.com

In order to view the complete data, please login here

List of Corporate Actions

Announcement Date CA Type CA Impact CA Event ISIN
13-Dec-2018 New Bond - - US584688AJ43
Medicines Company/The has issued USD 172500M, 3.50% fixed rate bond due 15-Jan-2024.
08-Jan-2018 Asset Sale - - US00214WAE12
Medicines Company/The announced today that it has sold its infectious disease business unit to Melinta Subsidiary Corp.
29-Nov-2017 Propose Asset Sale - - US00214WAE12
Medicines Company/The announced today that it has signed an agreement to sell its infectious disease business to Melinta Subsidiary Corp.
31-Aug-2015 Purchase Stock Target Name Eshelman Ventures, LLC US00214WAE12
Eshelman Ventures, LLC today announced that it has acquired 944,537 shares of common stock of Medicines Company/The.
18-Dec-2015 Propose Asset Sale - - US00214WAE12
Medicines Company/The today announced that it has agreed to sell its Hemostasis Portfolio to Mallinckrodt plc.

Login to view more details

FactEntry

All of the financial data available on this page is sourced from FactEntry.